Association between the serotonin 2A receptor gene and tardive dyskinesia in chronic schizophrenia
- PMID: 11317227
- DOI: 10.1038/sj.mp.4000842
Association between the serotonin 2A receptor gene and tardive dyskinesia in chronic schizophrenia
Abstract
Tardive dyskinesia (TD) is a long-term adverse effect of antipsychotic drugs that are dopamine D2 receptor blockers.(1) Serotonin receptor antagonism has been proposed as a common mechanism contributing to the low extrapyramidal effects profile of atypical antipsychotic drugs.(2) We examined the association of three polymorphisms in the 5-HT2A receptor gene (HTR2A) with TD susceptibility--T102C(3) and his452tyr(4) in the coding region and A-1438G(5) in the promoter--in matched schizophrenia patients with (n = 59, SCZ-TD-Y) and without TD (n = 62, SCZ-TD-N) and normal control subjects (n = 96). The T102C and the A-1438G polymorphisms are in complete linkage disequilibrium but not his452tyr. There was a significant excess of 102C and -1438G alleles (62.7%) in the SCZ-TD-Y patients compared to SCZ-TD-N patients (41.1%) and controls (45.9%; chi(2) = 12.8, df = 2, P = 0.002; SCZ-TD-Y vs SCZ-TD-N, chi(2) = 11.4, df = 1, P = 0.0008, OR 2.41, 95% CI 1.43-3.99) and of 102CC and -1438GG genotypes (SCZ-TD-Y 42.4%, SCZ-TD-N, 16.1%, controls 20.8%, chi(2) = 13.3, df = 4, P = 0.01). The 102CC and the -1438GG genotypes were associated with significantly higher AIMS trunk dyskinesia scores (F = 3.9; df = 2, 116; P = 0.02) and more incapacitation (F = 5.0; df = 2, 115; P = 0.006). The his452tyr polymorphism showed no association with TD. These findings suggest that the 5-HT2A receptor gene is significantly associated with susceptibility to TD in patients with chronic schizophrenia. Previously reported association of the T102C and A-1438G polymorphisms with schizophrenia(6) may reflect association of a sub-group of patients with a susceptibility to abnormal involuntary movements related to antipsychotic drug exposure.
Comment in
-
Age and the relationship of dopamine D3, serotonin 2C and serotonin 2A receptor genes to abnormal involuntary movements in chronic schizophrenia.Mol Psychiatry. 2002;7(2):137-9. doi: 10.1038/sj.mp.4000960. Mol Psychiatry. 2002. PMID: 11840306 No abstract available.
Similar articles
-
Lack of association between serotonin-2A receptor gene (HTR2A) polymorphisms and tardive dyskinesia in schizophrenia.Mol Psychiatry. 2001 Mar;6(2):230-4. doi: 10.1038/sj.mp.4000847. Mol Psychiatry. 2001. PMID: 11317228
-
Association of dopaminergic and serotonergic genes with tardive dyskinesia in patients with chronic schizophrenia.Pharmacogenomics J. 2003;3(5):277-83. doi: 10.1038/sj.tpj.6500194. Pharmacogenomics J. 2003. PMID: 14583797
-
[Pharmacogenetic assessment of antipsychotic-induced tardive dyskinesia: contribution of 5-hydroxytryptamine 2C receptor gene and of a combination of dopamine D3 variant allele (Gly) and MnSOD wild allele (Val)].Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2003 Apr;20(2):98-102. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2003. PMID: 12673575 Chinese.
-
Atypical antipsychotics: mechanism of action.Can J Psychiatry. 2002 Feb;47(1):27-38. Can J Psychiatry. 2002. PMID: 11873706 Review.
-
[Genome-wide association analyses for neuroleptic-induced tardive dyskinesia].Nihon Shinkei Seishin Yakurigaku Zasshi. 2011 Aug;31(4):155-62. Nihon Shinkei Seishin Yakurigaku Zasshi. 2011. PMID: 21941849 Review. Japanese.
Cited by
-
Genetic Factors Associated With Tardive Dyskinesia: From Pre-clinical Models to Clinical Studies.Front Pharmacol. 2022 Jan 24;12:834129. doi: 10.3389/fphar.2021.834129. eCollection 2021. Front Pharmacol. 2022. PMID: 35140610 Free PMC article. Review.
-
The genetics of drug-related movement disorders, an umbrella review of meta-analyses.Mol Psychiatry. 2020 Oct;25(10):2237-2250. doi: 10.1038/s41380-020-0660-5. Epub 2020 Feb 4. Mol Psychiatry. 2020. PMID: 32020047
-
Excess of transmission of the G allele of the -1438A/G polymorphism of the 5-HT2A receptor gene in patients with schizophrenia responsive to antipsychotics.BMC Psychiatry. 2008 May 30;8:40. doi: 10.1186/1471-244X-8-40. BMC Psychiatry. 2008. PMID: 18513383 Free PMC article.
-
Antipsychotic-induced extrapyramidal symptoms in patients with schizophrenia: associations with dopamine and serotonin receptor and transporter polymorphisms.Eur J Clin Pharmacol. 2007 Mar;63(3):233-41. doi: 10.1007/s00228-006-0234-8. Epub 2007 Jan 17. Eur J Clin Pharmacol. 2007. PMID: 17225991
-
Pharmacogenetics of antipsychotic adverse effects: Case studies and a literature review for clinicians.Neuropsychiatr Dis Treat. 2007 Dec;3(6):965-73. doi: 10.2147/ndt.s1752. Neuropsychiatr Dis Treat. 2007. PMID: 19300635 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous